AssayIndex

CPC-2601-M2514

BPC-157 · 10 mg declared · Chinese Peptide Company Co., Ltd. · manufactured 18 Jan 2026

CHARACTERISED
Lot code
CPC-2601-M2514
Supplier
CPC — Chinese Peptide Company Co., Ltd.
Compound
BPC-157
Compound class
Tissue-repair and immunomodulatory peptides
Declared label claim
10mg
Manufacture date
18 Jan 2026
Index quarter
2026-Q2
Independent assays
6
Laboratories involved
PeptideMeter, Janoshik
Provenance mix
Supplier-supplied ×6
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 6
Median purity 98.46% n=6
Spread (max − min) 0.50pp n=6
Standard deviation 0.175pp n=6
96.897.397.998.599.099.6100.2This lot (CPC-2601-M2514)This lot (CPC-2601-M2514): Q1 98.34, median 98.46, Q3 98.51, n=6n=6All BPC-157All BPC-157: Q1 98.59, median 99.15, Q3 99.71, n=591n=591 Purity (% area)
Figure 1. This lot's independent purity results against the whole BPC-157 record set in the index. The vertical line is the index acceptance specification for the tissue-repair and immunomodulatory peptides class, 98.0 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 6

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043369CPC-2601-M2514PeptideMeter2026-Q298.525.99Supplier-supplied1MARGINAL
AX-2026-043370CPC-2601-M2514PeptideMeter2026-Q298.435.59Supplier-supplied1MARGINAL
AX-2026-043371CPC-2601-M2514Janoshik2026-Q298.236.4792.8Supplier-supplied1MARGINAL
AX-2026-043372CPC-2601-M2514PeptideMeter2026-Q298.315.6193.9Supplier-supplied1MARGINAL
AX-2026-043373CPC-2601-M2514Janoshik2026-Q298.496.54105.2Supplier-supplied1MARGINAL
AX-2026-043374CPC-2601-M2514Janoshik2026-Q298.736.46Supplier-supplied1MARGINAL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
PeptideMeter398.52, 98.43, 98.3198.4328min-0.0598.48
Janoshik398.23, 98.49, 98.7398.4930min+0.0098.49

This lot contributes 1 paired comparison to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)98.6498.52divergence +0.18 pp vs batch median
Total impurities (% area)1.361.48
Largest single impurity (% area)not stated1.06
Water (%)not stated5.99
Counter-ion (%)7.58.87
Peptide content (%w/w)88.4not determined
Endotoxin (EU/mg)not stated1.92
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
des-Gly truncate (−57 Da)6 / 60.550.02–1.27
pyroglutamate cyclisation (−17 Da)6 / 60.240.15–0.32
acetylated N-terminus (+42 Da)6 / 60.330.09–0.72
BPC-157 arginine-salt artefact6 / 60.030.03–0.04
[D-Val]-diastereomer6 / 60.260.02–0.66
truncated (1-12)6 / 60.030.01–0.05
Section 7

What this rollup does not establish